Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Thrombocytopenia 9Leukemia, Myeloid, Acute 8Leukemia 6Leukemia, Myelomonocytic, Chronic 4Myelodysplastic Syndromes 3Leukemia, Lymphocytic, Chronic, B-Cell 3Multiple Myeloma 2Lymphoma 2Leukemia, Myelomonocytic, Acute 2Leukemia, Monocytic, Acute 2Leukemia, Megakaryoblastic, Acute 2Leukemia, Erythroblastic, Acute 2Leukemia, Eosinophilic, Acute 2Leukemia, Basophilic, Acute 2Jacobs syndrome 2Hematologic Neoplasms 2Congenital Abnormalities 2Solid Tumor, Childhood 1Sarcoma 1Recurrence 1Purpura, Thrombocytopenic, Idiopathic 1Primary Myelofibrosis 1Pathologic Complete Response 1Osteosarcoma 1Neoplasms, Connective and Soft Tissue 1Lymphoma, Non-Hodgkin 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Myeloid, Chronic-Phase 1

Interventions

romiplostim 1oprelvekin 1hetrombopag 1eltrombopag 1avatrombopag 1Interleukin-11 1Injections 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Chemotherapy-induced Thrombocytopenia × eltrombopag × Clear all
NCT04600960 2025-02-24

Eltrombopag for Chemotherapy-induced Thrombocytopenia

Institute of Hematology & Blood Diseases Hospital, China

Phase 2 Recruiting
50 enrolled
Classical hematology

Chemotherapy-induced Thrombocytopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡